Skip to main content
Explore URMC

KL2TR001999 Gilmore ReFOCUS

Research Question:
cancer study

Basic Study Information

The purpose of the study is to examine the feasibility and safety of twelve weeks oral supplementation of Epigallocatechin-3-gallate (EGCG) in older survivors of cancer

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher:  Nikesha Gilmore

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search